Clinical Trial

Application of DCE-MRI Based on 4D FreeBreathing in Predicting the Efficacy of Immune and Targeted Therapy in Lung Cancer

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 19, 2024 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to address the challenge of predicting the efficacy of targeted and immunotherapy in lung cancer patients. By utilizing two DCE-MRI images-one before treatment and one after one treatment cycle-along with the patients' clinical and pathological information, we aim to achieve accurate prediction of the therapeutic efficacy of targeted and immunotherapy in lung cancer patients.
Trial Details
NCT Number NCT06742021
Lead Sponsor Yunnan Cancer Hospital
Conditions Lung Cancer
Enrollment 195 participants
Start Date 2024-11-11
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2024-12-19